BIA Investor Breakfast - Future of the UK: Industrial Strategy and Patient Capital Review

BIA and our hosts Stifel invite you to join them for an informal networking breakfast and special panel event to discuss the Patient Capital Review and other factors that will impact the growth of the UK biotech sector in the coming years.

We’ll be joined by ex-science and Treasury minister, Lord David Willetts to give his personal insight and experience, alongside other experts on the sector.

Open to investors, fund managers and brokers ONLY

Programme

08.00 - 08.50  Registration and networking breakfast

08:50 - 09.00  Welcome

09.00 - 09.10  Review of BIA/Informa Q2 Finance Report
                           Max Herrmann, Managing Director, Stifel

09.10 - 09.25  Brexit and the future of regulation
                           Steve Bates OBE, Chief Executive Officer, BIA

09.25 - 9.45    The future of the UK - Industrial Strategy and Patient Capital Review
                          Panel:
                          Steve Bates, OBE, Chief Executive Officer, BIA
                          Kym Denny, Chief Executive Officer, hVIVO
                          Max Herrmann, Managing Director, Stifel
                          Lord David Willetts 

09.45 - 10.00   Q&A

10.00 - 10.30   Refreshments and networking

10.30 Close

Venue

Stifel
150 Cheapside
London
EC2V 6ET

 

Kindly hosted by